These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 11168952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progression of diabetic nephropathy in normotensive type 1 diabetic patients.
    Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH.
    Kidney Int Suppl; 1999 Jul; 71():S101-5. PubMed ID: 10412749
    [Abstract] [Full Text] [Related]

  • 6. Progression of nephropathy in type 2 diabetic patients.
    Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.
    Kidney Int; 2004 Oct; 66(4):1596-605. PubMed ID: 15458456
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH, Rossing P, Hommel E, Smidt UM.
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Smoking and progression of diabetic nephropathy in type 1 diabetes.
    Hovind P, Rossing P, Tarnow L, Parving HH.
    Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
    Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH.
    Diabetologia; 2004 Nov; 47(11):1936-9. PubMed ID: 15551047
    [Abstract] [Full Text] [Related]

  • 12. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.
    Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O.
    Nephrol Dial Transplant; 2002 Aug; 17(8):1408-12. PubMed ID: 12147787
    [Abstract] [Full Text] [Related]

  • 13. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
    Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH.
    Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
    [Abstract] [Full Text] [Related]

  • 14. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA, Nielsen FS, Smidt UM, Parving HH.
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [Abstract] [Full Text] [Related]

  • 15. Constant glomerular filtration rate in diabetic nephropathy. Correlation to blood pressure and blood glucose control.
    Nyberg G, Blohmé G, Nordén G.
    Acta Med Scand; 1986 Oct; 219(1):67-72. PubMed ID: 3082107
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P, Tarnow L, Oestergaard PB, Parving HH.
    Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.